Onderneming Lpath, Inc. Nasdaq
Aandelen
US5489103060
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 73 | 01-01-05 | |
Thomas Neudeck
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Brian Szymczak
CMP | Compliance Officer | 51 | 01-10-14 |
Vance Brown
BRD | Director/Board Member | 54 | - |
Keely Scamperle
PRN | Corporate Officer/Principal | - | 17-01-22 |
Kirk Ellis
SAM | Sales & Marketing | - | 10-05-21 |
Sales & Marketing | - | 10-05-21 | |
Mike Gutteridge
SAM | Sales & Marketing | - | 01-03-16 |
Comptroller/Controller/Auditor | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Vance Brown
BRD | Director/Board Member | 54 | - |
Jonathan Monson
BRD | Director/Board Member | 50 | 04-04-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 57 971 919 | 38 371 462 ( 66,19 %) | 0 | 66,19 % |
Bedrijfsgegevens
Apollo Endosurgery, Inc.
1120 South Capital of Texas Highway Suite 300
78746, Austin
+
http://apolloendo.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+73,24% | 12,42 mld. | |
-19,09% | 7,81 mld. | |
+5,88% | 6,4 mld. | |
+13,24% | 5,45 mld. | |
+38,48% | 5,01 mld. | |
-17,30% | 4,84 mld. | |
-19,78% | 4,19 mld. | |
-29,53% | 2,69 mld. | |
+47,29% | 2,39 mld. |
- Beurs
- Aandelen
- Koers APEN
- Koers
- Onderneming Lpath, Inc.